氟班色林

氟班色林（CAS 167933-07-5）的独立参考数据，整理自公开化学数据库。

各数据库的登记标识

计算分子描述符

在册的记载用途

Preparation: M. Turconi et al., European Patent Office patent 526434; G. Bietti et al., USA patent 5576318 (1993, 1996 both to Boehringer Ingelheim).Flibansetrin is indicated for the treatment of women less than 65 years of age with acquired, generalized hypoactive sexual desire disorder (HSDD) as characterized by low sexual desire that causes marked distress or interpersonal difficulty and is not due to: - A co-existing medical or psychiatric condition, - Problems within the relationship, or - The effects of a medication or other drug substance. In Canada, it is approved for the same indication but in women less than 60 years of age.

同义词与商品名

Flibanserin; 167933-07-5; Bimt-17; Addyi; Bimt 17; Ectris; Girosa; BIMT 17 BS; BIMT-17-BS; flibanserina; Flibanserine; 37JK4STR6Z; 1,3-Dihydro-1-(2-(4-(3-(trifluoromethyl)phenyl)-1-piperazinyl)ethyl)-2H-benzimidazol-2-one; 3-[2-[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]ethyl]-1H-benzimidazol-2-one; Female Viagra (Street Name); Female Viagra [Street Name]

GHS 危害分类

Reported hazard statements	H301 (92.7%), H315 (95.1%), H319 (95.1%), H335 (92.7%)

H301 (92.7%): Toxic if swallowed [Danger Acute toxicity, oral]

H315 (95.1%): Causes skin irritation [Warning Skin corrosion/irritation]

公开数据库对它的描述

Flibanserin · CAS 167933-07-5 · C20H21F3N4O. UNII 37JK4STR6Z.

物理形态与操作说明

数据来源：PubChem / Wikidata；与随货 COA 不一致时以 COA 为准。